A Greenburg Traurig team represented Intec Pharma Ltd. in a public offering that raised $57.5 million that the company intends to use to fund further clinical trials of a product that could improve the treatment of symptoms of advanced Parkinson's disease.
August 30, 2017 at 04:00 PM
1 minute read
A Greenburg Traurig team represented Intec Pharma Ltd. in a public offering that raised $57.5 million that the company intends to use to fund further clinical trials of a product that could improve the treatment of symptoms of advanced Parkinson’s disease.
The platform technology on which the product is based is also part of a proposed medical marijuana drug that is in clinical trials in Israel.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Duane Morris LLP seeks a highly motivated junior associate to join its dynamic and growing Labor and Employment Class Action group in Chicag...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Tired of the stress of the big city? Are you looking to improve your quality of life? Then consider practicing law at the Jersey Shore. Pe...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
